Company news
Algorae Pharmaceuticals Limited news in 2016
Algorae Pharmaceuticals Limited's news releases, calls and decks from 2016, newest first.
Group 2 Parkinsons trial patients treatment completed
December 22, 2016
Reinstatement to Official Quotation
November 29, 2016
Suspension from Official Quotation
November 27, 2016
Approval granted for group 2 in Parkinsons trial
November 10, 2016
Appendix 4C Quarterly Cash Flow Report 30 September 2016
October 19, 2016
Group 1 patients successfully treated in Parkinsons trial
October 4, 2016
LCTs joint venture focuses on US developments
August 22, 2016
NTCELL demonstrates continued reversal of Parkinsons
June 7, 2016
LCT JV secures funds to realise the potential of DIABECELL
March 30, 2016
LCT starts Phase IIb clinical trial of NTCELL
March 23, 2016
LCT completes $2.8m private placement and announces SPP
February 16, 2016
LCT receives ethics approval for Phase IIb Parkinsons trial
February 11, 2016
NTCELL reverses the progression of Parkinsons disease
February 10, 2016